Transaction in Own Shares & TVR

RNS Number : 0158D
Transense Technologies PLC
17 October 2022
 

Transense Technologies plc

("Transense" or the "Company")

 

Transaction in own shares

Change to Total Voting Rights

 

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that further to the announcement on 27 September 2022, the Company has purchased 10,000 of its own ordinary shares of 10p each ("Ordinary Shares") at a price of 69.75 pence per share. These shares will be held in treasury for the time being to satisfy share option awards in the future.

Following this transaction, the total number of Ordinary Shares held as treasury shares by the Company is 444,000. The total number of Ordinary Shares in issue (including shares held as treasury shares) is 16,437,740. Therefore, the total number of voting rights in the Company is 15,993,740 which may  be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.  

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the information below contains information about the purchases made by Shard Capital Stockbrokers on behalf of the Company as part of the buyback programme.

 

Aggregate information:

Shares purchased:

Transense Technologies plc (ISIN CODE: GB00BDHDTH21)

Date of purchases:

1 4 October 2022

Investment firm

Shard Capital Stockbrokers

Venue

London Stock Exchange

Number of ordinary shares purchased

10,000

Volume-weighted average price, pence

69.75

Highest price paid (per ordinary share), pence

69.75

Lowest price paid (per ordinary share), pence

69.75

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper / Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com


Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring.  Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense 's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, electric motors & drives, industrial machinery and performance automotive. 

The Company 's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.  www.transense.com  .

For further information please contact transense@walbrookpr.com

 


Schedule of Purchases - Individual Transactions

 

Number of Shares

Price Per Share (pence)

Trading Venue

Date of Transaction

Time of transaction

10,000

69.75

London Stock Exchange

14 October 2022

16:39:07

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEANESFESAFEA
UK 100

Latest directors dealings